CTYNasdaqPharmaceutical PreparationsFiscal year ends December 31
CITY THERAPEUTICS, INC.
$21.46−0.94 (-4.20%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About City Therapeutics
Pharmaceutical Preparations, SIC 2834
CITY THERAPEUTICS, INC. is listed on Nasdaq under the ticker CTY, in the SEC industry Pharmaceutical Preparations. It is incorporated in Delaware and its fiscal year ends on December 31.
Company profile
Company
- Legal name
- CITY THERAPEUTICS, INC.
- Headquarters
- Cambridge, MA
- Address
- 399 Binney St 02141
- Phone
- (857) 357-2024
- Website
- citytx.com
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- CTY
- Exchange
- Nasdaq
- IPO date
- Oct 16, 2026
- SEC CIK
- 2143850
- EIN
- 93-2762122
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
City Therapeutics's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 16, 2026 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 13, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |